HALO

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Corporate Conference

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Corporate Conference

Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 10K

Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 8K

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Other Release

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Release

Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38% growth year-over-year.…

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Conference

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Announcement

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Tram Bui — Head of…